Pharma BD Deal Intelligence
Endo Pharmaceuticals Holdings Inc. / Qualitest Pharmaceuticals
2010 · Acquisition/Merger · $1.2B · Complete
Announcement Sentiment
88
Strongly positive
Endo agreed to acquire Qualitest from Apax Partners for $1.2B cash, diversifying into generics. Closed December 1, 2010.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Accretive
Pipeline outcome
Assets Advanced
Assessment window: 5yr post-close.
Key facts
- Announced Sep 28, 2010
- Closed Dec 01, 2010
- Deal value $1.2B
- Deal type Acquisition/Merger
- Therapeutic area Branded and generic pharmaceuticals
- Indications Branded and generic pharmaceuticals
- Key assets Generic pharmaceuticals portfolio
- Mechanism Generic pharmaceuticals
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals